tk88 bet

Doctors’ treatment protocols save severely ill COVID-19 patients

Doctors and scientists in Vietnam who have been using various therapies and medicines to treat COVID-19, a new disease that has no standard treatment protocols, have been able to save a number of critically ill patients.
Doctors’ treatment protocols save severely ill COVID-19 patients ảnh 1The British pilot with Vietnam Airlines is recovering from COVID-19 at Cho Ray Hospital in HCM City. (Photo: VNA)

HCMCity (VNS/VNA) - Doctors and scientists in Vietnam who have beenusing various therapies and medicines to treat COVID-19, a newdisease that has no standard treatment protocols, have been able to save anumber of critically ill patients.

A 43-year-old patient, a British pilot with Vietnam Airlines, who wascritically ill for months, is now being treated at Cho RayHospital in HCM City, where he has had a "miraculous recovery",according to a report from the National Steering Committee forCOVID-19 Prevention and Control.

The patient has not had to use ventilation for 60 hours, andrespiration has recovered. He is conscious and can communicate withdoctors and nurses. His kidneys, heart, and liver functions have alsoimproved.

However, the muscle strength of his legs remains weak. Hehas physical therapy twice a day, and no longerneeds antibiotics. 

As of June 15, the patient had spent 89 daysin treatment, the most of any COVID-19 patient in the country.

Before being transferred to Cho Ray, he was treated at the HCM CityHospital for Tropical Diseases. His lungs recovered 30 percent of theircapacity at that time.  

Dr Nguyen Thanh Phong, head of the HCM City Hospital for TropicalDiseases' department for infectious diseases D, told Vietnam News that“During treatment, doctors at the hospital and Cho Ray Hospital discussednew therapies to treat him.”

“We decided to use the anticoagulant Xarelto, which has neverbeen used in hospitals in Vietnam, to replace the drug heparin that hadbeen used when he was on the ECMO (extracorporeal membraneoxygenation) machine, which pumps blood out of the body and removes carbondioxide and sends oxygen-filled blood back.”

“The patient was allergic to heparin, which reduces platelet count andcauses bleeding, threatening his life. So the drug heparin wasstopped,” Phong said.

The anticoagulant was used for 10 days until medicine imported fromGermany arrived. 

The other severely ill COVID-19 patient at HCM City Hospital forTropical Diseases was transferred from the Mekong Delta province of Bac Lieu’sGeneral Hospital on May 10.

After 23 days of treatment, she recovered and was discharged on June 1.  
“Herlung was damaged more severely than the pilot’s. She suffered vaginal bleeding.After treatment, her health was OK,” Phong said.

The National Hospital for Tropical Diseases has also treated a number ofseverely ill COVID-19 patients.

In one case, the heart of a 64-year-old woman with COVID-19 fromHanoi stopped beating on three occasions. An ECMO machine was used tomaintain her life for 17 days. She also received dialysis treatment. 

At one point, her heart stopped beating for 40 minutes,but hospital doctors provided emergency aid in time to save her.   

After more than two months of treatment, her lung function improved andshe was able to communicate with the hospital’s doctors andnurses. On May 27, she was discharged from the hospital.

Another severely ill COVID-19 patient, 88, was treated initiallyat the National Hospital for Tropical Diseases and then Bach Mai Hospitalfor further treatment.

The patient, from Hung Yen province, had suffered an intracranialhaemorrhage, which paralysed one side of herbody, before testing positive for SARS-CoV-2 on April 14.

Because of her health status, the National Hospital for Tropical Diseases’doctors and nurses had to frequently keep watch by the patient’s bedside toadjust her medicine.

The treatment helped the patient recover. Respiration gradually improvedand ventilation was no longer needed.  

The patient tested free of SARS-CoV-2 and was transferred to BachMai Hospital for further treatment on May 5.  

The woman was the country's oldest COVID-19 patient treated at ahospital.

Vietnam has had no deaths caused by COVID-19 so far, Dr Luong Ngoc Khue,head of the Department of Medical Examination and Treatment under the Ministryof Health, said.

According to the Ministry of Health, 325out of the 335 confirmed cases or 97 percent, have recovered andbeen discharged from hospitals. The country has seen no new COVID-19 infectionsin the community for 62 consecutive days./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🃏 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

ꦰ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

⛦ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|